Retatrutide: The Next Generation of Medical Weight Loss
Learn About Retatrutide at Evolve Health & Wellness
At Evolve Health & Wellness, we are committed to staying at the forefront of evidence-based obesity medicine. One of the most exciting medications currently under clinical investigation is Retatrutide, a next-generation therapy that has demonstrated remarkable weight loss results in clinical trials.
Although Retatrutide is not currently FDA-approved and remains an investigational medication, ongoing research suggests it may become one of the most effective medical weight loss therapies available in the future.
Our team closely follows the latest advances in obesity treatment so we can help patients understand emerging therapies and determine which currently approved options may best fit their individual health goals.
Consultation required before treatment protocol is prescribed.
What Is Retatrutide?
Retatrutide is an investigational once-weekly injectable medication developed to treat obesity and metabolic disease.
Unlike current medications that target one or two hormone pathways, Retatrutide is the first triple hormone receptor agonist, activating:
- GLP-1 (Glucagon-Like Peptide-1)
- GIP (Glucose-Dependent Insulinotropic Polypeptide)
- Glucagon receptors
By influencing all three pathways simultaneously, researchers believe Retatrutide may provide greater effects on appetite regulation, metabolism, and energy expenditure than previous generations of weight loss medications.
How Does Retatrutide Work?
Weight management is controlled by a complex network of hormones that influence hunger, fullness, insulin function, and calorie utilization.
Retatrutide works by activating three naturally occurring hormone systems:
GLP-1
- Reduces appetite
- Slows stomach emptying
- Promotes fullness
- Improves blood sugar regulation
GIP
- Enhances insulin response
- Supports healthy glucose metabolism
- May improve fat utilization
Glucagon
Unlike traditional weight loss medications, Retatrutide also activates glucagon receptors, which may:
- Increase energy expenditure
- Support fat metabolism
- Help offset the slowing of metabolism that often occurs during weight loss
Researchers believe this triple-action approach may contribute to the substantial weight loss observed in clinical trials.
Potential Benefits of Retatrutide
Clinical studies suggest Retatrutide may help patients:
- Achieve substantial weight loss
- Reduce appetite and food cravings
- Improve portion control
- Increase feelings of fullness
- Improve insulin sensitivity
- Support healthy blood sugar regulation
- Improve metabolic health
- Reduce waist circumference
- Enhance overall quality of life
While these findings are encouraging, Retatrutide remains under investigation, and additional studies are ongoing.
Clinical Trial Results
Retatrutide has generated significant interest because of the weight loss achieved in large clinical studies.
In Phase 3 clinical trials, participants receiving the highest dose experienced an average weight reduction of approximately 28% of their starting body weight over 80 weeks, with many individuals achieving weight loss of 30% or more. These results are among the largest reported for any obesity medication studied to date.
It is important to remember that clinical trial outcomes do not guarantee individual results, and Retatrutide has not yet completed the FDA approval process.
Who May Benefit in the Future?
If approved by the FDA, Retatrutide may become an option for adults who:
- Have struggled with long-term weight management
- Are seeking physician-guided medical weight loss
- Are committed to sustainable lifestyle changes
Eligibility will ultimately depend on FDA-approved indications and your healthcare provider’s clinical evaluation.
How Does Retatrutide Compare to Semaglutide and Tirzepatide?
Retatrutide builds upon earlier generations of weight loss medications.
Medication
Hormones Targeted
Current Status
Semaglutide
GLP-1
FDA approved
Tirzepatide
GLP-1 + GIP
FDA approved
Retatrutide
GLP-1 + GIP + Glucagon
Investigational
The addition of glucagon receptor activity may contribute to increased energy expenditure, which researchers believe could partly explain the greater weight loss observed in clinical trials. More long-term data are still being collected.
Possible Side Effects
The most commonly reported side effects in clinical studies include:
- Nausea
- Vomiting
- Diarrhea
- Constipation
- Heartburn
- Bloating
- Decreased appetite
- Mild abdominal discomfort
These side effects are similar to those seen with other GLP-1–based therapies and were generally most noticeable during dose escalation.
Because Retatrutide remains investigational, researchers continue to evaluate its long-term safety and effectiveness.
Why Choose Evolve Health & Wellness?
At Evolve Health & Wellness, we believe aesthetic treatments should enhance your natural beauty—not change who you are.
When you choose our clinic, you’ll receive:
- Experienced medical providers
- Individualized treatment plans
- Natural-looking results
- Advanced injection techniques
- Honest aesthetic recommendations
- Comfortable, personalized care
- Ongoing follow-up and support
Our goal is to help you look refreshed, confident, and authentically you.
Frequently asked questions
No. Retatrutide is currently an investigational medication and has not been approved by the U.S. Food and Drug Administration. It is still undergoing Phase 3 clinical evaluation.
Clinical trials have shown some of the largest average weight reductions reported for an investigational obesity medication, making it one of the most closely watched developments in metabolic medicine.
Stay Informed with Evolve Health & Wellness
Obesity medicine is evolving rapidly, and our providers are committed to helping patients understand the latest treatment options.
If you’re interested in physician-guided medical weight loss or would like to learn about current therapies and emerging treatments, schedule a consultation with Evolve Health & Wellness today.
